KR100415283B1 - Method of producing cla and mushroom mycelium culture containing same - Google Patents
Method of producing cla and mushroom mycelium culture containing same Download PDFInfo
- Publication number
- KR100415283B1 KR100415283B1 KR10-2000-0042024A KR20000042024A KR100415283B1 KR 100415283 B1 KR100415283 B1 KR 100415283B1 KR 20000042024 A KR20000042024 A KR 20000042024A KR 100415283 B1 KR100415283 B1 KR 100415283B1
- Authority
- KR
- South Korea
- Prior art keywords
- cla
- culture
- mycelium
- mushroom
- mushroom mycelium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 버섯균의 배양에 의해 CLA를 생산하는 방법 및 이에 의해 생산된 CLA를 함유하는 버섯 균사체 및 배양물, 그리고 이를 이용하는 방법에 관한 것으로, 리놀렌산을 포함하는 배지에서 버섯 균주를 액체 배양하는 단계를 포함하는 방법에 의하면 강력한 항암성, 면역 증강성, 체지방 감소성 등의 효과를 갖는 CLA (conjugated linoleic acid)를 효율적으로 생산할 수 있으며, 이와 같이 생산된 CLA를 함유하는 버섯 균사체 및 배양물은 버섯 균사체와 배양액의 생리 활성에 CLA의 기능이 추가되어 상승적인 효과를 발휘할 수 있게 되므로, 식품 등에 첨가하여 기능성 식품의 제조에 활용할 수 있다.The present invention relates to a method for producing CLA by culturing mushrooms, and to mushroom mycelium and culture containing the CLA produced thereby, and a method of using the same, the method comprising liquid culturing mushroom strains in a medium containing linolenic acid According to the method comprising a can effectively produce CLA (conjugated linoleic acid) having the effect of strong anticancer, immune enhancement, body fat reduction, mushroom mycelium and culture containing the CLA produced in this way Since the function of CLA is added to the physiological activity of the mycelium and the culture medium to exert a synergistic effect, it can be added to foods and the like and used for the production of functional foods.
Description
본 발명은 버섯균의 배양에 의해 CLA를 생산하는 방법 및 이에 의해 생산된 CLA를 함유하는 버섯 균사체 및 배양물, 그리고 이를 이용하는 방법에 관한 것이다.The present invention relates to a method for producing CLA by culturing mushrooms, mushroom mycelium and culture containing the CLA produced thereby, and a method of using the same.
현재까지 CLA(conjugated linoleic acid)는 리놀렌산(linoleic acid)이나 이를 함유하는 지방으로부터 알카리 이성화 방법에 의해 화학적으로 합성하거나,비. 피브리솔벤즈(B. fibrisolvens)와 같은 반추위 미생물이나,엘. 류테리(L.reuteri)등의 미생물에 의해 생산되고 있다.엘. 류테리(L. reuteri)는 장내 유용 세균의 일종으로 CLA를 생성하는 미생물로 밝혀져 요쿠르트 등의 발효 제품 생산에 이용되고 있다.To date, CLA (conjugated linoleic acid) is linolenic acid (linoleic acid) or chemically synthesized by the alkaline isomerization method from fat, or non-containing them. Ruminant microorganisms such as B. fibrisolvens, or L. It is produced by microorganisms such as L. reuteri . L. L. reuteri is a microorganism that produces CLA as a useful intestinal bacterium and has been used to produce fermentation products such as yogurt.
화학적인 방법으로 대량 합성된 CLA는 건강보조용 등으로 사용되고 있다. 또한 반추위에서 유래한 미생물에 의해 합성된 CLA는 육고기나 우유 등에 전이되어 이들 제품에 소량 함유되어 있다.엘. 류테리(L. reuteri)에 의해 합성된 CLA는 우유, 요쿠르트 등의 제품 생산에 이용되고 있다.CLA synthesized in a large amount by chemical methods is used for health supplements and the like. In addition, CLA synthesized by microorganisms derived from the rumen is transferred to meat or milk and contained in a small amount in these products. L. CLA synthesized by L. reuteri is used to produce products such as milk and yogurt.
한편, 버섯 균사체는 β-D-글루칸과 같은 다당체를 함유하거나 버섯 균사체 자체가 갖는 특수한 물질로 인해 항암성, 면역증강성 등과 같은 생리활성을 갖는다. 버섯균사체 배양액은 버섯균의 종류나 배양액의 조성에 따라서 다양한 물질이 생성된다.On the other hand, mushroom mycelium contains a polysaccharide such as β-D-glucan or has a physiological activity such as anti-cancer, immuno-enhancing, etc. due to a special material possessed by the mushroom mycelium itself. The mushroom mycelium culture medium produces various substances depending on the type of mushroom bacteria or the composition of the culture medium.
본 발명에서는 현재까지 CLA 생산 방법으로서는 알려진 적이 없는 고등균류인 버섯 균사체를 배양하는 방법에 의해 높은 효율로 CLA를 제조하는 방법을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a method for producing CLA with high efficiency by a method of culturing mushroom mycelium which is a higher fungus which has not been known as a CLA production method up to now.
본 발명의 다른 목적은 CLA를 함유하는 버섯 균사체 및 배양물을 제공하고, 이를 기능성 식품 등에 이용하는 방법을 제공하고자 하는 것이다.Another object of the present invention is to provide a mushroom mycelium and culture containing CLA, and to provide a method of using the same for functional foods.
도 1은 본 발명에 따라 버섯 균사체의 액체 배양에 의해 얻어진 배양액에서추출한 지방산의 GC 분석 차트,1 is a GC analysis chart of fatty acids extracted from a culture solution obtained by the liquid culture of mushroom mycelium according to the present invention,
도 2는 본 발명에 따라 버섯 균사체의 액체 배양에 의해 얻어진 배양액에 함유된 c9,t11 CLA의 MS 분석 차트,2 is an MS analysis chart of c9, t11 CLA contained in a culture obtained by liquid culture of mushroom mycelium according to the present invention;
도 3은 본 발명에 따른 버섯 균사체의 액체 배양시엘. 류테리(L. reuteri)가 c9,t11 CLA 생성량에 미치는 영향을 보여주는 GC 분석 차트이다.3 is a liquid culture of mushroom mycelium according to the present invention . GC analysis chart showing the effect of L. reuteri on c9, t11 CLA production.
상기 목적을 달성하기 위한 본 발명의 CLA 제조 방법은, 리놀렌산을 포함하는 배지에서 버섯 균주를 액체 배양하는 단계를 포함하는 것을 특징으로 한다.CLA production method of the present invention for achieving the above object, characterized in that it comprises the step of liquid culture of the mushroom strain in a medium containing linolenic acid.
여기에서, 리놀렌산을 포함하는 배지는 대두 및 대두박의 효소 분해물이나, 식용유 가수 분해물을 포함하는 것이 바람직하고,엘. 류테리(L. reuteri)를 첨가하여, 25∼35 ℃에서 진탕 또는 폭기 하에 1∼7 일 동안 배양하는 것이 더욱 바람직하다.Here, the culture medium containing linoleic acid is preferred, including soybean and soybean meal hydrolyzate or enzyme, vegetable oil hydrolyzate, and El. It is more preferable to add L. reuteri and incubate for 1-7 days at 25-35 ° C. under shaking or aeration.
또한, 본 발명에서는 상기 방법에 의해 제조된 CLA를 함유하는 버섯 균사체 및 배양물 및 이를 식품에 첨가하여 기능성 식품을 제조하는 방법을 제공한다.In addition, the present invention provides a mushroom mycelium and culture containing the CLA prepared by the above method and a method for producing a functional food by adding it to food.
본 발명에서는 특수하게 제조된 배양액에서 버섯균을 액체 배양 방법으로 배양함으로써 CLA를 생산하고, 이와 같이 생성된 CLA를 함유하는 버섯 균사체 및 배양물을 제조할 수 있었다. 이때, 버섯균에엘. 류테리(L. reuteri)를 첨가하면 천연 CLA의 생성량을 증가시킬 수 있어 바람직하다.In the present invention, CLA was produced by culturing mushroom bacteria in a specially prepared culture solution in a liquid culture method, and mushroom mycelium and culture containing the CLA thus produced could be prepared. At this time, L. mushrooms . The addition of L. reuteri is preferred because it can increase the amount of natural CLA produced.
이와 같이 생산된 버섯 균사체 및 배양물에 함유되어 있는 CLA는 버섯 균사체나 버섯 균사체액이 갖는 기능성에 상승 효과를 나타내거나 CLA가 갖는 여러 가지 생리 활성을 부여할 수 있을 것이다. 즉, 버섯 균사체는 β-D-글루칸과 같은 다당체를 함유하거나 버섯 균사체 자체가 갖는 특수한 물질로 인해 항암성, 면역 증강성 등과 같은 생리 활성을 가지며, 버섯 균사체 배양액은 버섯균의 종류나 배양액의 조성에 따라서 다양한 물질이 생성된다. 여기에 배양에 의해 생성된 CLA가 포함되면 버섯 균사체의 생리 활성에 CLA의 기능이 추가되어 상승적인 효과를 발휘할 수 있게 된다.The CLA contained in the mushroom mycelium and the culture thus produced may have a synergistic effect on the functionality of the mushroom mycelium or the mushroom mycelium solution or impart various physiological activities of the CLA. In other words, the mushroom mycelium contains a polysaccharide such as β-D-glucan or has a physiological activity such as anticancer activity or immunity enhancement due to a special substance possessed by the mushroom mycelium itself. Depending on the various materials are produced. If the CLA produced by the culture is included here, the function of CLA is added to the physiological activity of the mushroom mycelium, thereby enabling a synergistic effect.
이하, 실시예를 통하여 본 발명을 상세히 설명한다. 단, 하기의 실시예는 본 발명의 예시일 뿐 본 발명이 이들 만으로 제한되는 것은 아니다. 각각의 실시예는반복 실시하여 그 결과의 재현성을 확인하였다.Hereinafter, the present invention will be described in detail through examples. However, the following examples are only examples of the present invention, and the present invention is not limited thereto. Each example was repeated to confirm the reproducibility of the results.
[실시예 1] 기본 버섯 균사체 배양액의 조성과 배양Example 1 Composition and Culture of Basic Mushroom Mycelia Culture Solution
버섯 균사체의 액체 배양에 의한 CLA의 생성 여부를 실험하기 위해 사용된 기본 배지와 배양 조건은 다음과 같다.The basal medium and culture conditions used to test the production of CLA by liquid culture of mushroom mycelium are as follows.
① 버섯 균주: 느타리(Pleurotus ostreatus; PO) 외 8 종① Mushroom Strains: Pleurotus ostreatus (PO) and 8 other species
② 배지 조성: 리놀렌산원으로는 리놀렌산을 다량 함유하는 대두 및 대두박을 물에 불려 믹서로 충분히 마쇄시켰다. 여기에 프로테아제, 셀루라아제, 리파아제 등의 효소를 처리(60 ℃, 200 rpm, 1-5 시간)하였다. 리놀렌산원으로서 홍아씨유 등을 첨가하는 경우는 식용유를 알카리로 가수분해한 식용유 가수분해물을 사용하였다. 여기에 황백당, MgSO4, KH2PO4를 첨가하고 증류수로 1 ℓ가 되도록 조정하였다. 이것을 멸균한 다음 기본 배지로 사용하였다.② Medium composition: As the linolenic acid source, soybean and soybean meal containing a large amount of linolenic acid were soaked in water and sufficiently ground by a mixer. Enzymes, such as protease, cellulase, and lipase, were processed here (60 degreeC, 200 rpm, 1-5 hours). In the case of adding red seed oil or the like as a linolenic acid source, an edible oil hydrolyzate obtained by hydrolyzing the cooking oil with alkali was used. To this was added sulfur white sugar, MgSO 4 , KH 2 PO 4 and adjusted to 1 L with distilled water. This was sterilized and used as basal medium.
③ 배양 조건: 25∼35 ℃에서 진탕 또는 폭기하여 1∼7 일 동안 배양하였다.③ Cultivation conditions: incubation for 1-7 days by shaking or aeration at 25 ~ 35 ℃.
[실시예 2] 버섯 균사체 배양에 의해 생성된 CLA의 확인 및 정량Example 2 Identification and Quantification of CLA Produced by Mushroom Mycelia Culture
실시예 1에서 배양된 균사체 및 배양액에 CLA 생성 유무를 조사하기 위하여, 먼저 버섯 균사체를 회수한 후 클로로포름:메탄올(2:1, v/v)로 마쇄 추출하여 지방산을 추출하고 메틸화하여 GC로 CLA를 분석하였다.In order to investigate the presence of CLA in the cultured mycelium and the culture medium in Example 1, the mushroom mycelium was first recovered, followed by trituration with chloroform: methanol (2: 1, v / v) to extract fatty acids, methylation, and CLA with GC. Was analyzed.
도 1은 본 발명에 따라 버섯 균사체의 액체 배양에 의해 얻어진 배양액에서 추출한 지방산의 GC 분석 차트이다.1 is a GC analysis chart of fatty acids extracted from a culture solution obtained by the liquid culture of mushroom mycelium according to the present invention.
GC 차트 상에서 피크를 MS로 확인한 결과 CLA임이 밝혀졌다.The peak was identified by MS on the GC chart and found to be CLA.
도 2는 본 발명에 따라 버섯 균사체의 액체 배양에 의해 얻어진 배양액에서 추출한 지방산의 MS 분석 차트로 CLA임을 확인할 수 있다.Figure 2 can be confirmed that the CLA in the MS analysis chart of the fatty acid extracted from the culture solution obtained by the liquid culture of the mushroom mycelium according to the present invention.
[실시예 3] 대두박의 농도에 따른 CLA 생성량 변화[Example 3] CLA production amount change according to the concentration of soybean meal
실시예 1의 기본 배지에서 대두박의 농도를 달리하여 배양(25 ℃, 7 일, 폭기)하고 실시예 2의 방법으로 CLA 생성량을 측정하였다.The concentration of soybean meal in the basal medium of Example 1 was cultured (25 ° C., 7 days, aeration), and the amount of CLA was measured by the method of Example 2.
표 1은 대두박의 함량이 CLA 생성량에 미치는 영향을 나타낸 것으로 단위는 ㎎ CLA/g 지방이다. 대조군에서는 CLA가 검출되지 않았으며, 대두박의 농도에 따라 CLA의 농도도 증가하였는데, 대두박의 농도가 6 % 보다 높으면 더 이상의 CLA 농도 증가가 없음을 알 수 있다.Table 1 shows the effect of soybean meal content on the production of CLA, the unit is mg CLA / g fat. In the control group, no CLA was detected, and the concentration of CLA increased with the concentration of soybean meal. If the concentration of soybean meal was higher than 6%, no increase in CLA concentration was observed.
[실시예 4] 배양 기간 및 공기 유입 방법에 따른 CLA 생성량 변화[Example 4] CLA production amount according to the culture period and air inflow method
실시예 1의 기본 배지에 대두박의 농도를 6.0 %로 고정하고 25 ℃에서 배양 기간 및 에어레이션 방법을 달리하여 생성된 CLA의 함량을 조사하였다.The concentration of soybean meal in the basal medium of Example 1 was fixed at 6.0%, and the content of CLA produced by varying the incubation period and aeration method at 25 ° C was investigated.
표 2는 배양 기간이 CLA 생성량에 미치는 영향을 나타낸 것으로, 폭기하면서배양한 경우이고, 표 3은 에어레이션 방법이 CLA 생성량에 미치는 영향을 나타낸 것으로, 7 일 동안 배양한 결과이다. 단위는 양쪽 모두 ㎎ CLA/g 지방이다. 실시 조건에서 CLA 생성량은 배양 7 일에 가장 높고 에어레이션 방법에서는 폭기 방식이 진탕 배양에 비해 CLA 생성량이 많은 것을 알 수 있다.Table 2 shows the effect of the incubation period on the production of CLA, a culture in aeration, Table 3 shows the effect of the aeration method on the production of CLA, the result of incubation for 7 days. The unit is both mg CLA / g fat. In the conditions of the CLA production is the highest in 7 days of culture, and the aeration method in the aeration method, it can be seen that the amount of CLA production compared to the shaking culture.
[실시예 5]Example 5 엘. 류테리(L. reuteri)L. L. reuteri 첨가에 따른 CLA 생성량 변화Changes in CLA Production with Addition
실시예 4에서 얻은 결과, 즉 대두박의 농도를 6.0 %로 조절한 기본 배지에서 폭기하면서 7 일 동안 배양한 결과를 기본으로 하고 (1) 기본 +엘. 류테리(L. reuteri)와 (2) 기본 +엘. 류테리(L. reuteri)+ MRS 배지(0.1 %)로 37 ℃에서 2 일 동안 배양한 후 CLA 생성량을 조사하였다.Based on the results obtained in Example 4, namely the result of incubation for 7 days while aeration in a basal medium in which the concentration of soybean meal was adjusted to 6.0% (1) basal + L. L. reuteri and (2) Basic + L. After culturing for 2 days at 37 ℃ with L. reuteri + MRS medium (0.1%), the amount of CLA production was investigated.
표 4는엘. 류테리(L. reuteri)가 버섯 균사체 배양시 CLA 생성량에 미치는 영향을 나타낸 것으로 단위는 ㎎ CLA/g 지방이다. 여기에서 보면엘. 류테리(L. reuteri)를 처리한 경우에 CLA 생성량이 기본군보다 증가하였고,엘. 류테리(L. reuteri)를 배양할 때 MRS를 첨가한 경우는 더욱 CLA 생성량이 높았다.Table 4 shows L. The effect of L. reuteri on CLA production in mushroom mycelium was expressed in mg CLA / g fat. Here you see El. Terry flow was when the handle (L. reuteri) is CLA production increase than the basic group, in El. In the case of L. reuteri culture, the amount of CLA was higher when MRS was added.
도 3은 본 발명에 따른 버섯 균사체의 액체 배양시엘. 류테리(L. reuteri)가 CLA 생성량에 미치는 영향을 보여주는 것이다.3 is a liquid culture of mushroom mycelium according to the present invention . It shows the effect of L. reuteri on CLA production.
[실시예 6] CLA 함유 배양 추출액(CLA-배양 추출액) 및 CLA 함유 배양 추출 엑기스 (CLA-엑기스) 조제Example 6 Preparation of CLA-containing culture extract (CLA-culture extract) and CLA-containing culture extract extract (CLA-extract)
실시예 3과 5의 액체 배양물 전체를 고온·고압으로 멸균 추출하여 CLA-배양추출액을 얻었다. 이 추출액을 고압 진공으로 농축하여 농축된 CLA-엑기스를 얻었다.The whole liquid culture of Examples 3 and 5 was sterilized and extracted at high temperature and high pressure to obtain a CLA-culture extract. This extract was concentrated under high pressure vacuum to give a concentrated CLA-extract.
[실시예 7] CLA 함유 균사체 농축액(CLA-균사체 농축액) 및 CLA 함유 균사체 분말 (CLA-균사체 분말)의 조제Example 7 Preparation of CLA-containing Mycelium Concentrate (CLA-mycelium Concentrate) and CLA-containing Mycelium Powder (CLA-Mycelium Powder)
CLA-버섯 균사체는 실시예 3이나 5에서 원심분리 또는 여과하여 얻거나 실시예 6에서 고압 추출 후에 남은 잔사로서 얻을 수 있다.CLA-mushroom mycelium can be obtained by centrifugation or filtration in Examples 3 or 5 or as a residue remaining after high pressure extraction in Example 6.
이들 균사체를 그대로 분말화하거나, 또는 이들 균사체에 노보자임 234 (Novo사 제품)를 처리(60 ℃에서 48 시간, 200 rpm 진탕)하여 원심분리 또는 여과하여 CLA-균사체 여액과 잔사를 얻었다. 여액을 진공 농축하여 CLA-균사체 농축액을 얻었다. 또한, 이 농축액을 진공 동결 건조 또는 열풍 건조하여 CLA-균사체 분말을 얻었다.The mycelium was powdered as it was, or the mycelium was treated with Novozyme 234 (manufactured by Novo Corporation) (48 hours at 60 ° C., 200 rpm shaking) to be centrifuged or filtered to obtain a CLA-mycelium filtrate and a residue. The filtrate was concentrated in vacuo to give a CLA-mycelia concentrate. In addition, the concentrated solution was vacuum lyophilized or hot air dried to obtain CLA-mycelium powder.
[실시예 8] CLA-배양 추출액, CLA-엑기스, CLA-균사체 농축액 및 CLA-균사체 분말의 식품 소재로서의 이용Example 8 Use of CLA-Culture Extract, CLA-Extract, CLA-Mycelium Concentrate and CLA-Mycelium Powder as Food Ingredients
실시예 6과 7에서 얻은 추출액, 엑기스, 농축액 및 분말을 각각 0.1∼5 중량% 농도로 첨가하여 CLA-버섯 균사체나 농축액을 함유하는 기능성 비스킷, 케익, 껌, 캔디, 쿠키 등의 제품을 제조하였다.Extracts, extracts, concentrates and powders obtained in Examples 6 and 7 were added at concentrations of 0.1 to 5% by weight, respectively, to prepare products such as functional biscuits, cakes, gums, candy, cookies, etc. containing CLA-mushroom mycelium or concentrate. .
또한 추출액, 엑기스, 농축액 및 분말을 각각 0.05∼100 중량% 농도로 첨가하여 통상의 음료 제조 방법에 따라 CLA-버섯 균사체나 농축액을 함유하는 기능성 음료를 제조하였다.In addition, extracts, extracts, concentrates and powders were each added at a concentration of 0.05 to 100% by weight to prepare functional drinks containing CLA-mushroom mycelium or concentrate according to a conventional beverage preparation method.
[실시예 9] CLA-배양 추출액, CLA-엑기스, CLA-균사체 농축액 및 CLA-분말을 이용한 캡슐, 과립, 정제의 제조Example 9 Preparation of Capsules, Granules, and Tablets Using CLA-Culture Extract, CLA-Extract, CLA-Mycelium Concentrate and CLA-Powder
실시예 6과 7에서 얻은 추출액, 엑기스, 농축액 및 분말을 0.1∼100 중량% 농도로 첨가하여 통상의 제조 방법에 따라 CLA-버섯 균사체나 농축액을 함유하는 기능성 캡슐, 과립, 정제 등을 제조하였다.Extracts, extracts, concentrates and powders obtained in Examples 6 and 7 were added at a concentration of 0.1 to 100% by weight to prepare functional capsules, granules, tablets and the like containing CLA-mushroom mycelium or concentrate according to a conventional production method.
이상에서 살펴 본 바와 같이, 본 발명에 따르면 강력한 항암성, 면역 증강성, 체지방 감소성 등의 효과를 갖는 CLA(conjugated linoleic acid)를 버섯균 액체 배양 방법에 의해 효율적으로 생산할 수 있다.As described above, according to the present invention, CLA (conjugated linoleic acid) having effects such as strong anticancer, immune enhancement, and body fat reduction can be efficiently produced by a mushroom culture method.
이와 같이 생산된 CLA를 함유하는 버섯 균사체 및 배양물은 버섯 균사체의 생리 활성에 CLA의 기능이 추가되어 상승적인 효과를 발휘할 수 있게 되므로, 식품 등에 첨가하여 기능성 식품의 제조에 활용될 수 있다.Mushroom mycelium and culture containing the CLA produced as described above can be used in the production of functional food by adding to food and the like, because the CLA function is added to the physiological activity of the mushroom mycelium can exhibit a synergistic effect.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0042024A KR100415283B1 (en) | 2000-07-21 | 2000-07-21 | Method of producing cla and mushroom mycelium culture containing same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0042024A KR100415283B1 (en) | 2000-07-21 | 2000-07-21 | Method of producing cla and mushroom mycelium culture containing same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020008967A KR20020008967A (en) | 2002-02-01 |
KR100415283B1 true KR100415283B1 (en) | 2004-01-16 |
Family
ID=19679271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0042024A KR100415283B1 (en) | 2000-07-21 | 2000-07-21 | Method of producing cla and mushroom mycelium culture containing same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100415283B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101283450B1 (en) | 2010-11-19 | 2013-07-15 | 신성식 | The cultivation method of the mushroom which contained the omega-3 using a fermentation container |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0691072A1 (en) * | 1994-07-08 | 1996-01-10 | MATHIESEN, Niels Lang | A method for cultivation of edible fungi |
WO1999029886A1 (en) * | 1997-12-05 | 1999-06-17 | Bjoerck Lennart | Formation of conjugated unsaturated fatty acids |
KR19990046012A (en) * | 1999-03-10 | 1999-06-25 | 조성인 | The production method of tea or drink utilizing the myceloid Phellinus Linteus or Agaricus blazei |
-
2000
- 2000-07-21 KR KR10-2000-0042024A patent/KR100415283B1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0691072A1 (en) * | 1994-07-08 | 1996-01-10 | MATHIESEN, Niels Lang | A method for cultivation of edible fungi |
WO1999029886A1 (en) * | 1997-12-05 | 1999-06-17 | Bjoerck Lennart | Formation of conjugated unsaturated fatty acids |
KR19990046012A (en) * | 1999-03-10 | 1999-06-25 | 조성인 | The production method of tea or drink utilizing the myceloid Phellinus Linteus or Agaricus blazei |
Non-Patent Citations (1)
Title |
---|
Nahrung. 1978;22(7):603-7. German * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101283450B1 (en) | 2010-11-19 | 2013-07-15 | 신성식 | The cultivation method of the mushroom which contained the omega-3 using a fermentation container |
Also Published As
Publication number | Publication date |
---|---|
KR20020008967A (en) | 2002-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ghorai et al. | Fungal biotechnology in food and feed processing | |
US4032663A (en) | Process for using cell wall-lysing enzymes | |
Martin et al. | Growth parameters for the yeast Rhodotorula rubra grown in peat extracts | |
KR100227329B1 (en) | Process for preparing mycelium extract | |
CA1042375A (en) | Fermentative removal of water-soluble carbohydrates in plant protein products | |
CA1039672A (en) | PRODUCTION OF .alpha.-GALACTOSIOASE BY PENICILLIUM DUPONTI | |
CN111493292B (en) | A method for preparing refined paste from marine organism and/or marine product processing waste | |
KR101039381B1 (en) | The fermentated liquor of Spirulina and the mamufacturing method thereof | |
KR101942958B1 (en) | Lactic acid bacteria ferments of pear pomace, the method for preparation and the use thereof | |
CN1060518C (en) | Method for producing dictyophora indusiata nutritive mycelium using bamboo fungus submerged culture fermentation technology | |
史敏 et al. | Optimum condition of ecologic feed fermentation by Pleurotus ostreatus using soybean curd residue as raw materials | |
Azeke et al. | Comparative effect of boiling and solid substrate fermentation using the tempeh fungus (Rhizopus oligosporus) on the flatulence potential of African yambean (Sphenostylis stenocarpa L.) seeds | |
KR100415283B1 (en) | Method of producing cla and mushroom mycelium culture containing same | |
KR20160079388A (en) | Korean Traditional Meju Prepared by Modified Process and Manufacturing Method of Doenjang and Soy Sauce Using the Same | |
KR0133989B1 (en) | Soy sauce using mushroom and method for production thereof | |
JP5081485B2 (en) | Anticancer agent and method for producing anticancer agent | |
Michalak et al. | Functional fermented food and feed from seaweed | |
CN101492708B (en) | Method for preparing vegetable seed peptide with single bioactivity by mix bacterium solid state fermentation | |
KR101771488B1 (en) | Novel Bacillus coagulans NRR1207, fermented ginseng using the same and probiotic composition containing the same | |
Paranthaman et al. | Optimization of fermentation conditions for production of tannase enzyme by Aspergillus oryzae using sugarcane baggasse and rice straw | |
US3890198A (en) | Cell wall-lysing complex enzymes and a process for the production thereof | |
CN103614301A (en) | Aspergillus niger for producing hydrolase and application of aspergillus niger in preparation of mushroom zymolyte | |
Eyal | Mushroom mycelium grown in submerged culture—Potential food applications | |
Raj et al. | Isolation, characterization and antioxidant activity of lipase enzyme producing yeasts isolated from spoiled sweet sample | |
KR20030019650A (en) | Mycellium beverage and Process for Preparing mycellium beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20110104 Year of fee payment: 8 |
|
LAPS | Lapse due to unpaid annual fee |